275 filings
Page 5 of 14
8-K
0vf24opca mw2zctd758
14 Aug 18
Other Events
5:24pm
8-K
2541x09
1 Aug 18
Vanda Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:19pm
8-K
cqxww n594iwf
13 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vjve6lrj
1 Jun 18
Entry into a Material Definitive Agreement
4:28pm
8-K
ufn9y0lodd239ttfj67
23 May 18
Other Events
4:01pm
8-K
dbo6 ke7lcda
2 May 18
Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results
4:07pm
8-K
wlqyeu
25 Apr 18
Departure of Directors or Certain Officers
5:01pm
8-K
5p6bljwr3fcmqaf7
23 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
87f9j
13 Apr 18
Other Events
12:00am
8-K
m03n3wcf3gntna
26 Mar 18
Other Events
12:00am
8-K
kd261bg99fvn2outk41
16 Mar 18
Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock
12:00am
8-K
dd8rq45lzy
14 Mar 18
Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
12:00am
8-K
6og eunx2qz8lugpv4k
5 Mar 18
Other Events
12:00am
8-K
als1ez
1 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
ripq73f 81q413ump
14 Feb 18
Vanda Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results
12:00am
8-K
or5q5 1ju8aoe9dy0
8 Jan 18
Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017
12:00am
8-K
tzft8up v7wd0xi7uf5
7 Nov 17
Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results
12:00am
8-K
58wyf
18 Oct 17
Other Events
12:00am
8-K
nf50ooss46xgjqjo6
13 Sep 17
Vanda’s Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis
12:00am
8-K
dw14xhtp
2 Aug 17
Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results
12:00am